Schedule for Rating Disabilities: The 83 FR 54250/ Final Rule/ 5 10/29/2018 Hematologic and Lymphatic N/A 12/9/2018 Systems VA Acquisition Regulation: Rule; Describing Agency Needs; 83 FR 54054/ 10/26/2018 Correction/ Contract Financing; N/A 10/31/2018 Correction Presumption of Herbicide Exposure and Presumption 83 FR 53179/ Final Rule/ 4 10/22/2018 of Disability During Service N/A 10/22/2018 for Reservists Presumed Exposed to Herbicides Adopting Standards for 83 FR 52345/ Proposed Rule/ 3 10/17/2018 Laboratory Requirements 12/17/2018 N/A Net Worth, Asset Transfers, Final Rule; 83 FR 52322/ 10/17/2018 and Income Exclusions for Correction/ N/A Needs-Based Benefits 10/18/2018 Loan Guaranty: Ability to Agency Repay Standards and determination; 83 FR 50506/ 2 10/9/2018 Qualified Mortgage status of interim N/A Definition Under the Truth in final rule/ Lending Act 10/9/2018 VA Acquisition Regulation: 83 FR 49302/ Final Rule/ 1 10/1/2018 Describing Agency Needs; N/A 10/31/2018 Contract Financing
5 10/29/2018 Schedule for Rating Disabilities: The Hematologic and Lymphatic Systems 83 FR 54250/ N/A Final Rule/ 12/9/2018 10/26/2018 VA Acquisition Regulation: Describing Agency Needs; Contract Financing; Correction 83 FR 54054/ N/A Rule; Correction/ 10/31/2018 4 10/22/2018 Presumption of Herbicide Exposure and Presumption of Disability During Service for Reservists Presumed Exposed to Herbicides 83 FR 53179/ N/A Final Rule/ 10/22/2018 3 10/17/2018 Adopting Standards for Laboratory Requirements 83 FR 52345/ 12/17/2018 Proposed Rule/ N/A 10/17/2018 Net Worth, Asset Transfers, and Income Exclusions for Needs-Based Benefits 83 FR 52322/ N/A Final Rule; Correction/ 10/18/2018 2 10/9/2018 Loan Guaranty: Ability to Repay Standards and Qualified Mortgage Definition Under the Truth in Lending Act 83 FR 50506/ N/A Agency determination; status of interim final rule/ 10/9/2018 1 10/1/2018 VA Acquisition Regulation: Describing Agency Needs; Contract Financing 83 FR 49302/ N/A Final Rule/ 10/31/2018
RegMgmt_FY_2019_RegsPublished_PrinterFriendly2.docx